• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在病态肥胖个体中,保守治疗和手术减肥后 C 反应蛋白、新蝶呤和乳铁蛋白的变化不同。

Changes in C-reactive protein, neopterin and lactoferrin differ after conservative and surgical weight loss in individuals with morbid obesity.

机构信息

Department of Surgery, Innlandet Hospital Trust, Gjøvik, Norway.

Department of Medicine and Geriatrics, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.

出版信息

Sci Rep. 2019 Nov 27;9(1):17695. doi: 10.1038/s41598-019-54107-z.

DOI:10.1038/s41598-019-54107-z
PMID:31776403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6881286/
Abstract

C-reactive protein, neopterin and lactoferrin are biomarkers of atherosclerotic disease. We aimed to assess changes in these biomarkers after conservative and surgical weight loss interventions in individuals with morbid obesity, to evaluate associations between biomarker changes and changes in body mass index and HbA1c, and to study associations between changes in the biomarkers. C-reactive protein, neopterin and lactoferrin were measured before and after conservative weight loss intervention and bariatric surgery. Data were analysed with mixed models. 137 individuals (mean age 43 years) were included. Body mass index decreased from 42.1 kg/m to 38.9 kg/m after the conservative intervention, and further to 30.5 kg/m after bariatric surgery. All biomarkers decreased after the conservative weight loss intervention. C-reactive protein and lactoferrin continued to decrease following bariatric surgery whereas neopterin remained stable. After adjustments for change in body mass index and HbA1c, all biomarkers decreased significantly after the conservative weight loss intervention, whereas none changed after bariatric surgery. There were no consistent correlations between changes in C-reactive protein, neopterin and lactoferrin. In conclusion, biomarkers of atherosclerosis decreased after weight loss interventions but had different trajectories. Neopterin, a marker related to atherosclerotic plaque stability, decreased after conservative weight loss but not following bariatric surgery.

摘要

C 反应蛋白、新蝶呤和乳铁蛋白是动脉粥样硬化疾病的生物标志物。我们旨在评估病态肥胖个体接受保守和手术减肥干预后这些生物标志物的变化,评估生物标志物变化与体重指数和 HbA1c 变化之间的关系,并研究生物标志物之间的变化关系。在保守减肥干预和减肥手术后测量 C 反应蛋白、新蝶呤和乳铁蛋白。使用混合模型分析数据。纳入了 137 名(平均年龄 43 岁)个体。体重指数从 42.1kg/m 下降到保守干预后的 38.9kg/m,进一步下降到减肥手术后的 30.5kg/m。所有生物标志物在保守减肥干预后均下降。C 反应蛋白和乳铁蛋白在减肥手术后继续下降,而新蝶呤保持稳定。在调整体重指数和 HbA1c 的变化后,保守减肥干预后所有生物标志物均显著下降,而减肥手术后无变化。C 反应蛋白、新蝶呤和乳铁蛋白之间没有一致的相关性。总之,动脉粥样硬化的生物标志物在减肥干预后下降,但轨迹不同。与动脉粥样硬化斑块稳定性相关的标志物新蝶呤在保守减肥后下降,但在减肥手术后没有下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a724/6881286/c30e49484e25/41598_2019_54107_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a724/6881286/a7d3637a2e3e/41598_2019_54107_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a724/6881286/c30e49484e25/41598_2019_54107_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a724/6881286/a7d3637a2e3e/41598_2019_54107_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a724/6881286/c30e49484e25/41598_2019_54107_Fig2_HTML.jpg

相似文献

1
Changes in C-reactive protein, neopterin and lactoferrin differ after conservative and surgical weight loss in individuals with morbid obesity.在病态肥胖个体中,保守治疗和手术减肥后 C 反应蛋白、新蝶呤和乳铁蛋白的变化不同。
Sci Rep. 2019 Nov 27;9(1):17695. doi: 10.1038/s41598-019-54107-z.
2
Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: a prospective cohort study.病态肥胖患者减肥干预后血清肠通透素的变化:一项前瞻性队列研究。
BMC Endocr Disord. 2020 Jul 22;20(1):108. doi: 10.1186/s12902-020-00594-5.
3
Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.Roux-en-Y 胃旁路术或袖状胃切除术前后血浆可溶性尿激酶型纤溶酶原激活物受体 (suPAR) 和高敏 C 反应蛋白水平:一项为期 1 年的前瞻性观察研究。
J Endocrinol Invest. 2021 Mar;44(3):599-608. doi: 10.1007/s40618-020-01358-7. Epub 2020 Jul 17.
4
Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity.肥胖症患者接受减重手术后,左、右心室在体重大幅减轻后的结构和功能变化。
Am J Cardiol. 2010 Feb 15;105(4):550-6. doi: 10.1016/j.amjcard.2009.09.057.
5
Bariatric surgery decreased the serum level of an endotoxin-associated marker: lipopolysaccharide-binding protein.减肥手术降低了一种内毒素相关标志物的血清水平:脂多糖结合蛋白。
Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1182-7. doi: 10.1016/j.soard.2014.02.022. Epub 2014 Feb 27.
6
Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.减肥手术导致的大量体重减轻对病态肥胖患者血清白细胞介素-18和单核细胞趋化蛋白-1水平的影响。
Obes Surg. 2006 Jun;16(6):709-15. doi: 10.1381/096089206777346763.
7
Emerging markers of atherosclerosis before and after bariatric surgery.减肥手术前后动脉粥样硬化的新兴标志物。
Obes Surg. 2015 Mar;25(3):486-93. doi: 10.1007/s11695-014-1407-7.
8
Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients.肥胖症患者接受减重手术后血浆醛固酮水平的变化。
BMC Endocr Disord. 2020 Apr 6;20(1):45. doi: 10.1186/s12902-020-0527-4.
9
Pre-surgical Weight Loss Predicts Post-surgical Weight Loss Trajectories in Adolescents Enrolled in a Bariatric Program.术前体重减轻可预测接受减重手术的青少年术后体重减轻轨迹。
Obes Surg. 2019 Apr;29(4):1154-1163. doi: 10.1007/s11695-018-03649-8.
10
Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery.减重手术后非糖尿病患者的动脉粥样硬化标志物改善。
Obes Surg. 2012 Nov;22(11):1701-7. doi: 10.1007/s11695-012-0706-0.

引用本文的文献

1
Prebiotic/probiotic supplementation resulted in reduced visceral fat and mRNA expression associated with adipose tissue inflammation, systemic inflammation, and chronic disease risk.补充益生元/益生菌可减少内脏脂肪,并降低与脂肪组织炎症、全身炎症及慢性病风险相关的mRNA表达。
Genes Nutr. 2022 Nov 28;17(1):15. doi: 10.1186/s12263-022-00718-7.
2
Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome.糖尿病患者的最佳体重指数是多少?从脂肪组织巨噬细胞衍生外泌体的角度来看。
Diabetes Metab Syndr Obes. 2022 Jan 13;15:141-153. doi: 10.2147/DMSO.S345890. eCollection 2022.
3
Relationship Between Serum Neopterin Level and Peripheral Arterial Plaque in Patients with Type 2 Diabetes.

本文引用的文献

1
Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice.血清 C 反应蛋白在心血管疾病预测中的作用:最新临床研究和公共卫生实践概述。
J Cell Physiol. 2018 Nov;233(11):8508-8525. doi: 10.1002/jcp.26791. Epub 2018 Jun 22.
2
The crucial roles of inflammatory mediators in inflammation: A review.炎症介质在炎症中的关键作用:综述
Vet World. 2018 May;11(5):627-635. doi: 10.14202/vetworld.2018.627-635. Epub 2018 May 15.
3
A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study.
2型糖尿病患者血清新蝶呤水平与外周动脉斑块的关系
Diabetes Metab Syndr Obes. 2021 Jun 28;14:2871-2878. doi: 10.2147/DMSO.S315986. eCollection 2021.
4
Lactoferrin-Loaded PEG/PLA Block Copolymer Targeted With Anti-Transferrin Receptor Antibodies for Alzheimer Disease.负载乳铁蛋白的聚乙二醇/聚乳酸嵌段共聚物,用抗转铁蛋白受体抗体靶向治疗阿尔茨海默病
Dose Response. 2020 Aug 14;18(3):1559325820917836. doi: 10.1177/1559325820917836. eCollection 2020 Jul-Sep.
5
Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: a prospective cohort study.病态肥胖患者减肥干预后血清肠通透素的变化:一项前瞻性队列研究。
BMC Endocr Disord. 2020 Jul 22;20(1):108. doi: 10.1186/s12902-020-00594-5.
6
Are the Results of a Combined Behavioural and Surgical Treatment of Morbid Obesity Satisfactory and Predictable?联合行为和手术治疗病态肥胖的结果是否令人满意且可预测?
Nutrients. 2020 Jul 5;12(7):1997. doi: 10.3390/nu12071997.
7
Changes in Faecal Short-Chain Fatty Acids after Weight-Loss Interventions in Subjects with Morbid Obesity.肥胖症患者体重减轻干预后粪便短链脂肪酸的变化。
Nutrients. 2020 Mar 18;12(3):802. doi: 10.3390/nu12030802.
一项保守的体重减轻干预措施可缓解肥胖型肠易激综合征患者的肠道症状:一项前瞻性队列研究。
J Obes. 2018 Mar 1;2018:3732753. doi: 10.1155/2018/3732753. eCollection 2018.
4
Multifunctional capacity and therapeutic potential of lactoferrin.乳铁蛋白的多功能能力及治疗潜力
Life Sci. 2018 Feb 15;195:61-64. doi: 10.1016/j.lfs.2018.01.002. Epub 2018 Jan 4.
5
Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis.针对肥胖成年人的体重减轻干预措施对死亡率、心血管疾病和癌症的影响:系统评价与荟萃分析
BMJ. 2017 Nov 14;359:j4849. doi: 10.1136/bmj.j4849.
6
Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications.肥胖症的遗传学:遗传关联研究告诉我们肥胖症及其并发症的生物学知识。
Lancet Diabetes Endocrinol. 2018 Mar;6(3):223-236. doi: 10.1016/S2213-8587(17)30200-0. Epub 2017 Sep 14.
7
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
8
Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study.病态肥胖患者中肠易激综合征的患病率及预测因素:一项横断面研究。
BMC Obes. 2017 Jun 29;4:22. doi: 10.1186/s40608-017-0159-z. eCollection 2017.
9
Obesity.肥胖
Nat Rev Dis Primers. 2017 Jun 15;3:17034. doi: 10.1038/nrdp.2017.34.
10
Health Effects of Overweight and Obesity in 195 Countries over 25 Years.25年间195个国家超重和肥胖对健康的影响
N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362. Epub 2017 Jun 12.